Sort by
Refine Your Search
-
Listed
-
Country
-
Employer
- University of North Carolina at Chapel Hill
- Nature Careers
- University of Oxford
- Rutgers University
- FAPESP - São Paulo Research Foundation
- Texas A&M University
- The Ohio State University
- University of Basel
- University of Miami
- University of Minnesota
- University of Oxford;
- CNRS
- Drexel University
- George Washington University
- Leiden University
- Northeastern University
- Stony Brook University
- The University of Arizona
- The University of Iowa
- Universitat de Barcelona
- University of Colorado
- University of Florida
- University of Kansas
- University of Kentucky
- University of Southern Denmark
- University of Sydney
- Utrecht University
- Aarhus University
- Baylor College of Medicine
- Delft University of Technology (TU Delft)
- Dublin City University
- ETH Zürich
- East Carolina University
- Empa
- Faculty of Pharmacy and Biochemistry University of Zagreb
- Ghent University
- ICN2
- IMoST - UMR INSERM 1240
- Indiana University
- Institut Pasteur
- Institut d'Investigació Biomèdica Sant Pau
- Institute for bioengineering of Catalonia, IBEC
- Karolinska Institutet (KI)
- King's College London
- Latvijas Organiskas Sintezes Instituts
- Leibniz
- Pennsylvania State University
- Purdue University
- THE UNIVERSITY OF HONG KONG
- Technical University of Denmark
- University of Amsterdam (UvA)
- University of Arkansas
- University of Bath
- University of Cincinnati
- University of Copenhagen
- University of Crete
- University of Kansas Medical Center
- University of London
- University of Nebraska Medical Center
- University of Oslo
- University of Turku
- University of Vermont
- University of Virginia
- Université Paris Cité
- Université de Bordeaux / University of Bordeaux
- Washington State University
- Wayne State University
- the National Medicines Institute
- 58 more »
- « less
-
Field
-
space while maintaining favourable pharmacological properties. A key feature of this project is the use of continuous-flow chemistry to enable the efficient, reproducible, and scalable synthesis
-
» Biomedical engineering Engineering » Other Mathematics » Statistics Medical sciences » Medicine Medical sciences » Veterinary medicine Medical sciences » Other Neurosciences » Neurology Pharmacological
-
30 Jan 2026 Job Information Organisation/Company Leiden University Research Field Biological sciences » Biology Pharmacological sciences Researcher Profile Recognised Researcher (R2) Application
-
Associate (Ion Channel & Receptor Physiology) who has: a PhD in neuroscience, physiology, pharmacology, or a related discipline strong hands‑on experience in electrophysiology and/or calcium imaging
-
Postdoctoral Research Associate - Training in Pediatric Cancer Survivorship Outcomes and Interventio
, computational biology, psychology and neuropsychology, neuroscience, exercise physiology, oncology, pharmacology, radiology, surgery and biostatistics. St. Jude leads two of the world's largest pediatric
-
Postdoctoral Research Associate - Basic and Translational Research Training in Pediatric Classical H
equipping them with the excitement, knowledge, and skills to make new biological discoveries and use modern tools for genetic and pharmacological manipulation to develop new therapies. Eligibility Applicants
-
20 Mar 2026 Job Information Organisation/Company the National Medicines Institute Department HR Department Research Field Pharmacological sciences » Pharmacy Researcher Profile Recognised Researcher
-
in experimental execution, data analysis, and statistical quality control. Required Education PhD in Toxicology, Pharmacology, Pathology, or related life science fields Required Experience Capable
-
or research career. Qualifications: PhD (or MD/PhD) in cancer biology, immunology, molecular biology, genetics, or a related field. Strong background in one or more relevant research areas (Pharmacology, Drug
-
University of North Carolina at Chapel Hill | Chapel Hill, North Carolina | United States | 2 months ago
pathways amenable to pharmacologic targeting. The aim is to better understand the clinical relevance of cancer stem cells and the interaction with the tumor microenvironment and underlying genetic driver